• In January 2025, Bureau Veritas and SGS entered advanced talks to merge and form a ~€32 billion global leader in testing & certification services, pending approval from major shareholders.

• In October 2024, Bureau Veritas acquired Massachusetts-based Aligned Incentives, integrating its AI-powered sustainability planning tools to enhance Scope 3 emissions analysis and support the LEAP 28 strategy for expanding sustainability services.

In this report, the Aerospace & Life Sciences Testing, Inspection, and Certification Market has been segmented by Service Type, Sourcing Type, Application and Geography.

Aerospace & Life Sciences Testing, Inspection, and Certification Market, Segmentation by Service Type

The Aerospace & Life Sciences Testing, Inspection, and Certification Market has been segmented by Service Type into Testing Services, Inspection Services and Certification Services.

Testing Services
Testing services dominate the market, accounting for nearly 45% of the overall revenue. These services are critical for verifying the structural integrity, performance, and safety of aerospace and life sciences components. With increasing regulatory mandates and safety standards, the demand for material, chemical, and non-destructive testing (NDT) is rising steadily across industries.

Inspection Services
Inspection services hold a significant share of approximately 35% in the Aerospace & Life Sciences TIC market. They involve the assessment of equipment, components, and systems to detect defects or deviations from specifications. The growth of advanced manufacturing and strict compliance standards is propelling the adoption of visual, dimensional, and automated inspection solutions.

Certification Services
Certification services contribute around 20% of the total market share. These services validate that processes, systems, and products meet national and international standards. Increasing global trade and cross-border manufacturing are boosting demand for ISO, FDA, and other regulatory certifications to ensure product safety and operational efficiency.

Aerospace & Life Sciences Testing, Inspection, and Certification Market, Segmentation by Sourcing Type

The Aerospace & Life Sciences Testing, Inspection, and Certification Market has been segmented by Sourcing Type into In-house and Outsourced.

In-house
In-house services account for around 55% of the market share, as many large aerospace and life sciences companies prefer maintaining internal testing, inspection, and certification units for greater control and confidentiality. This approach helps ensure regulatory compliance and faster turnaround times, especially for companies with high testing volumes or proprietary technologies.

Outsourced
Outsourced services represent approximately 45% of the market, driven by the need to access specialized expertise and reduce operational costs. Organizations increasingly rely on third-party TIC providers to manage complex regulatory frameworks, especially in emerging markets. Outsourcing is also gaining traction due to the scalability and flexibility it offers for periodic or project-specific requirements.

Aerospace & Life Sciences Testing, Inspection, and Certification Market, Segmentation by Application

The Aerospace & Life Sciences Testing, Inspection, and Certification Market has been segmented by Application into Medical & Life Sciences and Aerospace.

Medical & Life Sciences
Medical & Life Sciences account for nearly 50% of the total market share. This segment emphasizes the need for stringent compliance testing, biocompatibility assessments, and product certifications for medical devices, pharmaceuticals, and biotechnology products. Rising healthcare regulations and growing innovation in life sciences are driving strong demand for reliable TIC services in this space.

Aerospace
The aerospace segment contributes approximately 50% of the market, fueled by increasing investments in aircraft safety, component testing, and system certification. TIC services are crucial to ensure that aerospace components meet global safety standards. Advancements in aerospace engineering and production efficiency are further amplifying the need for specialized TIC solutions.

Aerospace & Life Sciences Testing, Inspection, and Certification Market, Segmentation by Geography

In this report, the Aerospace & Life Sciences Testing, Inspection, and Certification Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Aerospace & Life Sciences Testing, Inspection, and Certification Market Share (%), by Geographical Region

North America
North America leads the market with over 35% share, driven by a strong presence of major aerospace manufacturers and advanced healthcare infrastructure. The region’s stringent regulatory frameworks and demand for quality assurance continue to fuel the adoption of TIC services across sectors.

Europe
Europe holds a significant portion of the market, contributing around 30%. High emphasis on product safety, robust medical regulations, and advanced aerospace innovations are driving growth. Key countries like Germany, France, and the UK are prominent adopters of third-party testing and certification.

Asia Pacific
Asia Pacific is emerging as a high-growth region with a market share of approximately 20%. Increasing investments in healthcare infrastructure and a rapidly expanding aerospace sector are boosting demand for TIC services. Countries such as China, India, and Japan are leading regional contributors.

Middle East and Africa
The Middle East and Africa contribute around 8% of the market, with growth driven by rising medical device imports and evolving aerospace standards. Increasing regulatory focus and demand for quality compliance are promoting TIC adoption in the region.

Latin America
Latin America accounts for approximately 7% of the market. Growth is fueled by improvements in healthcare systems and expanding aerospace manufacturing hubs in countries like Brazil and Mexico. The region is gradually adopting global certification and inspection standards to enhance product reliability.

This report provides an in depth analysis of various factors that impact the dynamics of Aerospace & Life Sciences Testing, Inspection, and Certification Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers

• Increasing regulatory focus on quality assurance
• Rising demand for aerospace safety compliance
• Growth in biologics and medical devices

• Expansion of international trade and exports - The expansion of international trade and exports is playing a significant role in boosting the Aerospace & Life Sciences Testing, Inspection, and Certification (TIC) Market. As companies expand their global operations and product distribution, they are compelled to adhere to a wide range of regulatory and quality standards across various countries. This demand for multi-jurisdictional compliance is driving the need for reliable TIC services that can facilitate smooth entry into global markets while minimizing compliance risks. The aerospace sector, in particular, relies on internationally certified components and systems to ensure aircraft safety and operational integrity.

  Globalization has led to a more interconnected supply chain, where the sourcing, manufacturing, and assembly of aerospace and life sciences components span across continents. With this fragmentation, ensuring product reliability and safety becomes more complex, necessitating third-party inspection and certification to bridge potential quality gaps. Moreover, stringent regulations surrounding cross-border movement of medical devices, vaccines, and pharmaceuticals require a trusted verification mechanism, further cementing the role of TIC providers in these sectors.

  Increased emphasis on harmonization of global standards also amplifies the importance of TIC services. Various countries are aligning their national standards with international ones such as ISO, EN, and FAA/EASA frameworks. This evolution presents a significant opportunity for TIC providers to support companies in navigating compliance pathways while enhancing brand reputation and consumer trust. Standard harmonization simplifies the certification process but still necessitates detailed validation by expert TIC agencies.

  As international trade becomes more regulated and consumer expectations for safety and quality rise, companies are turning to TIC partners not just for certification, but for guidance in achieving operational excellence. This evolution underscores how the growth of global exports directly fuels the need for comprehensive, third-party testing and validation services in the aerospace and life sciences sectors.

Restraints

• High cost of certification processes
• Complex international regulatory frameworks
• Shortage of skilled TIC professionals

• Time-consuming and lengthy approval procedures - Time-consuming and lengthy approval procedures remain a major restraint for the Aerospace & Life Sciences TIC Market. Due to the highly regulated nature of both industries, each component, material, or device must pass through multiple layers of evaluation before it can be released to the market. These prolonged approval cycles can delay product launches, reduce manufacturing flexibility, and increase operational costs for stakeholders across the supply chain. The situation is particularly acute in life sciences, where safety protocols, clinical trials, and documentation requirements often extend into years.

  The time needed to conduct extensive testing, audits, and inspections not only slows down innovation but also discourages smaller enterprises from entering the market. SMEs may struggle to meet the time and resource commitments required for full certification, leading to missed opportunities and reduced competition in both aerospace and life sciences sectors. In an industry where speed-to-market can determine competitive advantage, any delay in compliance approval poses a significant commercial risk.

  Fragmented regulatory landscapes across geographies further compound the time-related issues. Even when companies adhere to internationally recognized standards, many local regulators impose additional verification, which requires repetition of tests or re-certification. This redundancy increases time burdens and stretches the already limited resources of testing labs and inspection agencies, especially during periods of increased demand or post-pandemic recovery phases.

  Manual documentation, outdated information systems, and bureaucratic inefficiencies add to the bottlenecks. Despite increasing digitalization in other areas, some TIC processes remain dependent on paper-based or semi-automated workflows, which prolong administrative approvals. In complex testing environments, the coordination among multiple stakeholders—regulatory bodies, manufacturers, and third-party auditors—further drags the process.

  Risk aversion within the sectors themselves contributes to delays. Due to the potentially catastrophic consequences of failure, regulators often err on the side of caution, which results in comprehensive, layered review structures. While necessary for public safety, these practices make it difficult to expedite the entry of new technologies or drugs without extensive trial cycles and peer-reviewed evidence.

Opportunities

• Digitalization of testing and inspection services
• Emerging markets demanding safety certifications
• Advancements in AI and automation testing

• Strategic outsourcing by life sciences firms - The strategic outsourcing by life sciences firms is creating a strong growth opportunity for the Aerospace & Life Sciences TIC Market. As life sciences companies focus more on core research and product innovation, they are increasingly delegating compliance, quality control, and regulatory affairs to third-party service providers. This trend allows TIC providers to position themselves as long-term strategic partners rather than just service vendors, adding recurring revenue streams and deeper integration into client operations.

  By outsourcing TIC functions, life sciences firms gain access to specialized knowledge, infrastructure, and personnel without the burden of maintaining internal compliance departments. This becomes especially valuable for organizations operating across multiple regions with varying regulatory requirements. The ability of TIC companies to navigate these differences with agility and consistency offers a compelling value proposition for pharmaceutical and biotech companies seeking both speed and accuracy in product rollouts.

  Outsourcing enables scalability. As demand surges for specific therapies or diagnostics—such as during a pandemic or disease outbreak—life sciences firms can ramp up production while relying on third-party TIC partners to maintain quality control across batches, locations, and delivery timelines. This flexibility helps reduce bottlenecks and ensures uninterrupted product flow to market, which is essential in both public health and commercial success.

  TIC companies are developing tailored service packages that bundle testing, certification, and regulatory consulting into cohesive solutions. These integrated models simplify vendor management for life sciences clients and allow TIC firms to increase their service footprint. By aligning more closely with the product lifecycle, these providers embed themselves deeply into the operational workflows of their clients, making disengagement unlikely and ensuring long-term contracts.

  Strategic partnerships also enable the adoption of new technologies. TIC providers often have the capability to introduce AI, machine learning, or blockchain solutions into the quality assurance process—something many pharmaceutical firms would find expensive or time-consuming to develop in-house. By leveraging these tools, clients can not only comply with regulations more efficiently but also reduce error margins and audit risks.

  In a landscape where regulation is intensifying and global market expansion is a priority, strategic outsourcing presents a clear path for TIC providers to scale. Those that offer comprehensive, technology-enabled, and regulatory-specific services will be best positioned to capitalize on this shift in business model among life sciences firms.

Key players in Aerospace & Life Sciences Testing, Inspection, and Certification Market include:

• SGS SA
• Intertek Group plc
• Bureau Veritas
• TÜV SÜD
• Eurofins Scientific
• TÜV Rheinland
• DNV GL
• Applus+
• ALS Limited
• Mistras Group
• TÜV Nord
• Element Materials Technology
• UL LLC

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Market Share Analysis
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis